Ciliary Body and Choroid Melanoma, Small Size Active Not Recruiting Phase 2 Trials for Sunitinib (DB01268)

IndicationStatusPhase
DBCOND0030836 (Ciliary Body and Choroid Melanoma, Small Size)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02068586Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaTreatment